Steris (FRA:2TG) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2TG Steris PLC FRA:2TG
83 GF Score
Price €189.70
GF Value €233.49
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Steris Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:2TG
83GF Score
Steris PLC FRA:2TG
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Steris (FRA:2TG) Overvalued in 2026?

Based on GuruFocus' analysis, Steris stock appears to be undervalued. The current stock price of €189.70 is trading 18.8% below its estimated GF Value™ of €233.49. GuruFocus considers Steris to be Modestly Undervalued.

Key valuation signals for FRA:2TG:

  • Dividends Received:
  • GF Value™: €233.49 vs. price of €189.70 (18.8% below fair value)
  • GF Score™: 83/100 with 1 warning sign

No single metric tells the full story. See the FRA:2TG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Steris Business Description

Other Exchanges STE:USAS1TE34:Brazil
Address 70 Sir John Rogerson\'s Quay, Dublin, IRL, D02 R296
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
83GF Score

Get the complete analysis for FRA:2TG

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€189.70
Price
€233.49
GF Value